Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts

Details 詳細情報について

• CRID

  1363388845898792064

• DOI

  10.1093/annonc/mdr463

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753419347064?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753419347064?httpAccept=text/plain

  http://academic.oup.com/annonc/article-pdf/23/5/1111/13705418/mdr463.pdf

• Data Source

  • Crossref